Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Eptinezumab 100 or 300 mg ev
DRUG
2 trials
Sponsors
University of Florence
Conditions
Chronic Migraine
Migraine
Migraine With Aura
Migraine Without Aura
Unknown Phase
Effectiveness and Tolerability of Eptinezumab
Completed
NCT06409845
University of Florence
Chronic Migraine, Migraine, Migraine With Aura +1
Start: 2024-03-26
End: 2026-04-01
Updated: 2026-06-11
The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)
Recruiting
NCT06628921
University of Florence
Migraine
Start: 2024-10-30
End: 2026-10-30
Target: 50
Updated: 2026-01-21
Related Papers
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).
2026-02-12